Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry


ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Research Article

Evaluation of Tissue and Serum Expression Levels of Lactate Dehydrogenase Isoenzymes in Patients with Head and Neck Squamous Cell Carcinoma

Author(s): Nooshin Mohtasham, Hossein Ayatollahi, Nasrollah Saghravanian, Reza Zare, Mohammad-Taghi Shakeri, Amirhossein Sahebkar* and Farnaz Mohajertehran*

Volume 19, Issue 17, 2019

Page: [2072 - 2078] Pages: 7

DOI: 10.2174/1871520619666191014160818

Price: $65


Background: Head and Neck Squamous Cell Carcinoma (HNSCC) is a common malignancy that is associated with high morbidity and mortality all over the world. We explored the role of mRNA expression of both subunits of LDH in the early diagnosis of HNSCC.

Materials and Methods: This was a case-control study on 62 healthy individuals and 62 patients with HNSCC. The expression of LDH in tumors and healthy tissue margins, and in the serum of both HNSCC patients and healthy individuals was evaluated using a quantitative real-time PCR method. Analysis of LDH-A and LDH-B expression and sensitivity-specificity analysis were carried out using SPSS software.

Results: mRNA expression levels of LDH-A (4.18±1.29) and LDH-B (2.85±1.07) isoenzymes in tumor tissues were significantly higher than the expressions in the corresponding healthy tissue margins (1.85±0.56 and 1.61±0.56 for LDH-A and LDH-B, respectively). A comparison of LDH-B expression between histological grade I tumor tissue (2.74±0.19) and marginal tissue (1.62±0.90) showed a significant difference (P=0.016). Patients with a positive history of alcohol consumption and cigarette smoking had significantly higher mRNA expression of LDH-A (P=0.024) and LDH-B (P=0.03) in the marginal tissue and blood, respectively. The highest sensitivity and specificity values pertained to the mRNA expression of LDH-A (90.9%) and LDH-B (85.5%) in the blood.

Conclusion: This is the first study reporting LDH gene expression as a biomarker in blood and tumoral tissue of HNSCC patients. Given the highest sensitivity and specificity values for LDH-A and LDH-B in blood, we recommend the simultaneous evaluation of both LDH isoenzymes in blood samples as a potential diagnostic method.

Keywords: Head and neck squamous cell carcinoma, lactate dehydrogenase, quantitative real-time PCR, early diagnosis, gene expression, mRNA.

Graphical Abstract
Ferlay, J.; Steliarova-Foucher, E.; Lortet-Tieulent, J.; Rosso, S.; Coebergh, J.W.; Comber, H.; Forman, D.; Bray, F. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur. J. Cancer, 2013, 49(6), 1374-1403.
[] [PMID: 23485231]
Ferlay, J.; Parkin, D.M.; Steliarova-Foucher, E. Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer, 2010, 46(4), 765-781.
[] [PMID: 20116997]
Huang, S.H.; O’Sullivan, B. Overview of the 8th edition TNM classification for head and neck cancer. Curr. Treat. Opt. Oncol, 2017, 18(7), 40.
Lane, A.N.; Fan, T.W.M.; Higashi, R.M. Metabolic acidosis and the importance of balanced equations. Metabolomics, 2009, 5(2), 163-165.
Gallo, M.; Sapio, L.; Spina, A.; Naviglio, D.; Calogero, A.; Naviglio, S. Lactic dehydrogenase and cancer: An overview. Front. Biosci., 2015, 20(20), 1234-1249.
[PMID: 25961554]
Hamanaka, R.B.; Chandel, N.S. Targeting glucose metabolism for cancer therapy. J. Exp. Med., 2012, 209(2), 211-215.
[] [PMID: 22330683]
Frezza, C.; Gottlieb, E. Mitochondria in cancer: Not just innocent bystanders. Semin. Cancer Biol., 2009, 19(1), 4-11.
[] [PMID: 19101633]
Alfarouk, K.O.; Shayoub, M.E.; Muddathir, A.K.; Elhassan, G.O.; Bashir, A.H. Evolution of tumor metabolism might reflect carcinogenesis as a reverse evolution process (dismantling of multicellularity). Cancers (Basel), 2011, 3(3), 3002-3017.
[] [PMID: 24310356]
Chen, C.Y.; Feng, Y.; Chen, J.Y.; Deng, H. Identification of a potent inhibitor targeting human lactate dehydrogenase A and its metabolic modulation for cancer cell line. Bioorg. Med. Chem. Lett., 2016, 26(1), 72-75.
[] [PMID: 26597536]
Curry, J.M.; Tuluc, M.; Whitaker-Menezes, D.; Ames, J.A.; Anantharaman, A.; Butera, A.; Leiby, B.; Cognetti, D.M.; Sotgia, F.; Lisanti, M.P.; Martinez-Outschoorn, U.E. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer. Cell Cycle, 2013, 12(9), 1371-1384.
[] [PMID: 23574725]
Zhang, H.F.; Wang, Y.C.; Han, Y.D. MicroRNA34a inhibits liver cancer cell growth by reprogramming glucose metabolism. Mol. Med. Rep., 2018, 17(3), 4483-4489.
[] [PMID: 29328457]
Robin, P.; Abgral, R.; Valette, G.; Le Roux, P.Y.; Keromnes, N.; Rousset, J.; Potard, G.; Palard, X.; Marianowski, R.; Salaun, P.Y. Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment. Eur. J. Nucl. Med. Mol. Imaging, 2015, 42(1), 72-78.
[] [PMID: 25169701]
Mohajertehran, F.; Sahebkar, A.; Zare, R.; Mohtasham, N. The promise of stem cell markers in the diagnosis and therapy of epithelial dysplasia and oral squamous cell carcinoma. J. Cell. Physiol., 2018, 233(11), 8499-8507.
[] [PMID: 29797575]
Neshati, V.; Bazzaz, B.S.F.; Mojarrad, M.; Neshati, Z.; Kerachian, M.A. Transduced mesenchymal stem cells and cardiomyogenic differentiation. J Cell Signal., 2018, 3(3), 187.
[] [PMID: 29637615]
Homaei Shandiz, F.; Fani, A.; Shakeri, S.; Sheikhi, M.; Ramezani Farkhani, A.; Shajiei, A.; Ayatollahi, H. Fluorescent in situ hybridization and real-time quantitative polymerase chain reaction to evaluate HER-2/neu status in breast cancer. Iran. J. Pathol., 2017, 12(1), 67-73.
[PMID: 29760755]
Bhattacharjee, A.; Giri, S.; Roy, M.; Chakraborty, A. Correlation of serum lactate dehydrogenase and alkaline phosphatase in different histological grades of head and neck squamous cell carcinoma and premalignant lesions. J. Cancer Res. Ther., 2018, 14(5), 934-940.
[] [PMID: 30197328]
Sharma, S. Tumor markers in clinical practice: General principles and guidelines. Indian J. Med. Paediatr. Oncol., 2009, 30(1), 1-8.
[] [PMID: 20668599]
Mohajertehran, F.; Ayatollahi, H.; Jafarian, A.H.; Khazaeni, K.; Soukhtanloo, M.; Shakeri, M.T.; Mohtasham, N. Overexpression of lactate dehydrogenase in the saliva and tissues of patients with head and neck squamous cell carcinoma. Rep. Biochem. Mol. Biol., 2019, 7(2), 142-149.
[PMID: 30805393]
Moosavi, M.S.; Keykha, E.; Fathi, Y. Letter to Editor: Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis. J. Oral Pathol. Med, 2016, 45(9), 721.
Kallalli, B.N.; Rawson, K. Muzammil; Singh, A.; Awati, M.A.; Shivhare, P. Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis. J. Oral Pathol. Med., 2016, 45(9), 687-690.
[] [PMID: 27132033]
Fan, J.; Hitosugi, T.; Chung, T.W.; Xie, J.; Ge, Q.; Gu, T.L.; Polakiewicz, R.D.; Chen, G.Z.; Boggon, T.J.; Lonial, S.; Khuri, F.R.; Kang, S.; Chen, J. Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells. Mol. Cell. Biol., 2011, 31(24), 4938-4950.
[] [PMID: 21969607]
Pereira, T.; Shetty, S.; Pereira, S. Estimation of serum lactate dehydrogenase level in patients with oral premalignant lesions/conditions and oral squamous cell carcinoma: A clinicopathological study. J. Cancer Res. Ther., 2015, 11(1), 78-82.
[] [PMID: 25879341]
Joshi, P.S.; Golgire, S. A study of salivary lactate dehydrogenase isoenzyme levels in patients with oral leukoplakia and squamous -cell carcinoma by gel electrophoresis method. J. Oral Maxillofac. Pathol., 2014, 18, S39-S44.
Shetty, S.R.; Chadha, R.; Babu, S.; Kumari, S.; Bhat, S.; Achalli, S. Salivary lactate dehydrogenase levels in oral leukoplakia and oral squamous cell carcinoma: A biochemical and clinicopathological study. J. Cancer Res. Ther., 2012, 8(Suppl. 1), S123-S125.
[PMID: 22322730]
Merza, K.S.; Alaaraji, S.B.; Abdullah, B.H. Comparative study on lactate dehydrogenase, alkaline phosphatase and immunoglobulins in serum and saliva of acute leukemia and oral squamous cell carcinoma patients. Iraqi J. Sci., 2010, 51, 262-270.
Rathy, R.; Deepa, M.G. Salivary tumour markers in oral cancer: Brief review. Oral Maxillofac. Pathol. J., 2012, 3, 238-243.
Markopoulos, A.K.; Michailidou, E.Z.; Tzimagiorgis, G. Salivary markers for oral cancer detection. Open Dent. J., 2010, 4, 172-178.
[] [PMID: 21673842]
Nagler, R.M.; Lischinsky, S.; Diamond, E.; Klein, I.; Reznick, A.Z. New insights into salivary lactate dehydrogenase of human subjects. J. Lab. Clin. Med., 2001, 137(5), 363-369.
[] [PMID: 11329534]
Ross, C.D.; Gomaa, M.A.; Gillies, E.; Juengel, R.; Medina, J.E. Tumor grade, microvessel density, and activities of malate dehydrogenase, lactate dehydrogenase, and hexokinase in squamous cell carcinoma. Otolaryngol. Head Neck Surg., 2000, 122(2), 195-200.
[] [PMID: 10652389]
Franceschi, S.; Levi, F.; Dal Maso, L.; Talamini, R.; Conti, E.; Negri, E.; La Vecchia, C. Cessation of alcohol drinking and risk of cancer of the oral cavity and pharynx. Int. J. Cancer, 2000, 85(6), 787-790.
[<787: AID-IJC8>3.0.CO;2-6] [PMID: 10709096]
Feng, L.; Wang, L. Effects of alcohol on the morphological and structural changes in oral mucosa. Pak. J. Med. Sci., 2013, 29(4), 1046-1049.
[] [PMID: 24353685]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy